Lioresal 10 mg Tablets আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

lioresal 10 mg tablets

novartis ireland limited - baclofen - tablet - 10 milligram(s) - other centrally acting agents; baclofen

BACLOFEN TABLET কানাডা - ইংরেজি - Health Canada

baclofen tablet

sanis health inc - baclofen - tablet - 10mg - baclofen 10mg - gaba-derivative skeletal muscle relaxants

BACLOFEN TABLET কানাডা - ইংরেজি - Health Canada

baclofen tablet

sanis health inc - baclofen - tablet - 20mg - baclofen 20mg - gaba-derivative skeletal muscle relaxants

BACLOFEN- baclofen tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

baclofen- baclofen tablet

remedyrepack inc. - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen tablets usp are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen tablets usp may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen tablets usp are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson’s disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.

LIORESAL 25 baclofen 25 mg tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

lioresal 25 baclofen 25 mg tablet bottle

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 25 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; wheat starch; microcrystalline cellulose; magnesium stearate; povidone - suppression of voluntary muscle spasm in: *multiple sclerosis, *spinal lesions of traumatic, infectious, degenerative, neoplastic and unknown origin, causing: - skeletal hypertonus - spastic and dyssynergic bladder dysfunction. not recommended in parkinson's disease or spasticity arising from strokes, cerebral palsy or rheumatoid disorders